Search research articles
Contact Us
Filters
Showing results (171-180 of 219) with videos related to
Page
of 22
Sort By:
Inflammatory Bowel Diseases
|
June 16, 2011
Constitutive activation of epithelial TLR4 augments inflammatory responses to mucosal injury and drives colitis-associated tumorigenesis
Masayuki Fukata, Limin Shang, Rebeca Santaolalla, et al.
Journal of Crohn'S & Colitis
|
October 5, 2023
Maintenance Risankizumab Sustains Induction Response in Patients with Crohn's Disease in a Randomized Phase 3 Trial
Marc Ferrante, Peter M Irving, Maria T Abreu, et al.
Gastroenterology
|
October 31, 2020
Epithelial TLR4 Signaling Activates DUOX2 to Induce Microbiota-Driven Tumorigenesis
Juan F Burgueño, Julia Fritsch, Eddy E González, et al.
Angiology
|
April 16, 2020
Aortic Stiffening Is an Extraintestinal Manifestation of Inflammatory Bowel Disease: Review of the Literature and Expert Panel Statement
Luca Zanoli, Dimitri P Mikhailidis, Rosa Maria Bruno, et al.
Biorxiv : the Preprint Server for Biology
|
February 3, 2025
Pretransplant targeting of TNFRSF25 and CD25 stimulates recipient Tregs in target tissues ameliorating GVHD post-HSCT
Duneia McManus, Sabrina N Copsel, Brent J Pffeifer, et al.
Inflammatory Bowel Diseases
|
December 23, 2009
Combination of innate and adaptive immune alterations increased the likelihood of fibrostenosis in Crohn's disease
Andrew Ippoliti, Shane Devlin, Ling Mei, et al.
Journal of Crohn'S & Colitis
|
June 1, 2022
Combining Pentoxifylline With Vedolizumab for Crohn's Disease: Results of a Randomised, Placebo-controlled Pilot Study
Shivali Berera, Stephanie C Ioannou, Diana Morillo, et al.
Biorxiv : the Preprint Server for Biology
|
September 4, 2024
An IL-17-DUOX2 axis controls gastrointestinal colonization by <i>Candida albicans</i>
Pallavi Kakade, Juan F Burgueno, Shabnam Sircaik, et al.
Alimentary Pharmacology & Therapeutics
|
October 21, 2020
Ustekinumab is effective and safe for ulcerative colitis through 2 years of maintenance therapy
Remo Panaccione, Silvio Danese, William J Sandborn, et al.
Cellular and Molecular Gastroenterology and Hepatology
|
December 4, 2025
Local Interactions Between Innate Immune Signaling, Microbiota, and Bile Acids Drive the Development of Duodenal Adenomas
Juan F Burgueño, Hajar Hazime, Julia Fritsch, et al.
Page
of 22
Search research articles
Search
Showing results (171-180 of 219) with videos related to
Sort By:
Page
of 22
Inflammatory Bowel Diseases
|
June 16, 2011
Constitutive activation of epithelial TLR4 augments inflammatory responses to mucosal injury and drives colitis-associated tumorigenesis
Masayuki Fukata, Limin Shang, Rebeca Santaolalla, et al.
Journal of Crohn'S & Colitis
|
October 5, 2023
Maintenance Risankizumab Sustains Induction Response in Patients with Crohn's Disease in a Randomized Phase 3 Trial
Marc Ferrante, Peter M Irving, Maria T Abreu, et al.
Gastroenterology
|
October 31, 2020
Epithelial TLR4 Signaling Activates DUOX2 to Induce Microbiota-Driven Tumorigenesis
Juan F Burgueño, Julia Fritsch, Eddy E González, et al.
Angiology
|
April 16, 2020
Aortic Stiffening Is an Extraintestinal Manifestation of Inflammatory Bowel Disease: Review of the Literature and Expert Panel Statement
Luca Zanoli, Dimitri P Mikhailidis, Rosa Maria Bruno, et al.
Biorxiv : the Preprint Server for Biology
|
February 3, 2025
Pretransplant targeting of TNFRSF25 and CD25 stimulates recipient Tregs in target tissues ameliorating GVHD post-HSCT
Duneia McManus, Sabrina N Copsel, Brent J Pffeifer, et al.
Inflammatory Bowel Diseases
|
December 23, 2009
Combination of innate and adaptive immune alterations increased the likelihood of fibrostenosis in Crohn's disease
Andrew Ippoliti, Shane Devlin, Ling Mei, et al.
Journal of Crohn'S & Colitis
|
June 1, 2022
Combining Pentoxifylline With Vedolizumab for Crohn's Disease: Results of a Randomised, Placebo-controlled Pilot Study
Shivali Berera, Stephanie C Ioannou, Diana Morillo, et al.
Biorxiv : the Preprint Server for Biology
|
September 4, 2024
An IL-17-DUOX2 axis controls gastrointestinal colonization by <i>Candida albicans</i>
Pallavi Kakade, Juan F Burgueno, Shabnam Sircaik, et al.
Alimentary Pharmacology & Therapeutics
|
October 21, 2020
Ustekinumab is effective and safe for ulcerative colitis through 2 years of maintenance therapy
Remo Panaccione, Silvio Danese, William J Sandborn, et al.
Cellular and Molecular Gastroenterology and Hepatology
|
December 4, 2025
Local Interactions Between Innate Immune Signaling, Microbiota, and Bile Acids Drive the Development of Duodenal Adenomas
Juan F Burgueño, Hajar Hazime, Julia Fritsch, et al.
Page
of 22